Stocktoria
Nuwellis, Inc. NUWE
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2012-02-16
Nuwellis, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 62.0% | 64.9% | 56.2% | 55.7% | 56.7% |
| Operating margin | -134.3% | -125.7% | -198.9% | -201.0% | -246.5% |
| Net margin | -211.9% | -127.7% | -228.0% | -170.0% | -246.9% |
| FCF margin | -131.8% | -110.4% | -204.0% | -178.8% | -228.0% |
| Return on assets | -286.4% | -113.2% | -206.8% | -58.9% | -64.3% |
| Return on equity | -667.7% | -171.0% | -675.9% | -117.5% | -75.4% |
| Current ratio | 1.71 | 3.46 | 2.59 | 4.86 | 8.50 |
| Revenue growth | -5.4% | -1.4% | 3.8% | 7.9% | 6.5% |
Source: SEC EDGAR filings · CIK 0001506492 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.